Elucidating the precise pharmacological mechanism of motion (MOA) of naturally occurring compounds could be challenging. Although Tarselli et al. (60) designed the initial de novo artificial pathway to conolidine and showcased that this By natural means happening compound effectively suppresses responses to equally chemically induced and inflammati